Philips Says DreamStation VOC Test Results Point to No Long-Term Health Consequences
23 Dicembre 2021 - 8:52AM
Dow Jones News
By Anthony O. Goriainoff
Koninklijke Philips NV said Thursday that test results of the
volatile organic compounds emissions of the first-generation
DreamStation devices show that exposure to the VOC's identified so
far isn't anticipated to result in long-term health consequences
for patients.
The Dutch health-technology group said that its overall guidance
for physicians and patients in June's recall notification was
unchanged at this time.
On June 14, the company's subsidiary, Philips Respironics,
issued a voluntary recall notification for certain sleep and
respiratory care products to address potential health risks related
to the polyester-based polyurethane sound abatement foam in these
devices.
Philips said it has conducted a comprehensive test and research
program on the foam to assess the potential patient health risks
related to possible emission of particulates from degraded foam and
certain VOCs.
"Comprehensive particulate testing and analyses are now expected
to be completed in the second quarter of 2022, as testing protocols
in compliance with the full extent of the relevant ISO standards
for all affected product platforms require long lead times of
multiple months," the company said.
Write to Anthony O. Goriainoff at
anthony.orunagoriainoff@dowjones.com
(END) Dow Jones Newswires
December 23, 2021 02:37 ET (07:37 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Apr 2023 a Apr 2024
